Citations for
Protection Against Insulin Resistance by Apolipoprotein M/Sphingosine 1-Phosphate.
Kurano M, Tsukamoto K, Shimizu T, Kassai H, Nakao K, Aiba A, Hara M, Yatomi Y.
Diabetes iabetes. 2020 Jan 8. pii: db190811. doi: 10.2337/db19-0811. [Epub ahead of print] 2020
Apolipoprotein M: new connections with diet, adipose tissue and metabolic syndrome.
Tavernier G, Caspar-Bauguil S, Viguerie N.
Curr Opin Lipidol 31(1):8-14. doi: 10.1097/MOL.0000000000000654. 2020
Apolipoprotein M induces inhibition of inflammatory responses via the S1PR1 and DHCR24 pathways.
Wang M, Luo GH, Liu H, Zhang YP, Wang B, Di DM, Zhan XH, Yu Y, Yao S, Zhang XY, Xu N.
Mol Med Rep 19(2):1272-1283. doi: 10.3892/mmr.2018.9747. Epub 2018 Dec 12. 2019
Expression of apolipoprotein M and its association with adiponectin in an obese mouse model.
Yang L, Li T, Zhao S, Zhang S.
Exp Ther Med 18(3):1685-1692. doi: 10.3892/etm.2019.7755. Epub 2019 Jul 9. 2019
Plasma apoM and S1P levels are inversely associated with mortality in African Americans with type 2 diabetes mellitus.
Liu M, Frej C, Langefeld CD, Divers J, Bowden DW, Carr JJ, Gebre AK, Xu J, Larsson B, Dahlbäck B, Freedman BI, Parks JS.
J Lipid Res 60(8):1425-1431. doi: 10.1194/jlr.P089409. Epub 2019 May 27. 2019
Apolipoprotein M/sphingosine-1-phosphate: novel effects on lipids, inflammation and kidney biology.
Bisgaard LS, Christoffersen C.
Curr Opin Lipidol 30(3):212-217. doi: 10.1097/MOL.0000000000000606. 2019
Apolipoprotein M in patients with chronic kidney disease.
Sørensen IM, Bertelsen M, Freese E, Lindhard K, Ullum H, Feldt-Rasmussen B, Nielsen LB, Christoffersen C, Bro S.
Atherosclerosis 275:304-311. doi: 10.1016/j.atherosclerosis.2018.06.815. Epub 2018 Jun 15. 2018
The Apolipoprotein M/S1P Axis Controls Triglyceride Metabolism and Brown Fat Activity.
Christoffersen C, Federspiel CK, Borup A, Christensen PM, Madsen AN, Heine M, Nielsen CH, Kjaer A, Holst B, Heeren J, Nielsen LB.
Cell Rep 22(1):175-188. doi: 10.1016/j.celrep.2017.12.029. 2018
Autophagy dysregulation caused by ApoM deficiency plays an important role in liver lipid metabolic disorder.
Zhang X, Zhang P, Gao J, Huang Q.
Biochem Biophys Res Commun 495(4):2643-2648. doi: 10.1016/j.bbrc.2017.12.148. Epub 2017 Dec 27. 2018
Apolipoprotein M mediates sphingosine-1-phosphate efflux from erythrocytes.
Christensen PM, Bosteen MH, Hajny S, Nielsen LB, Christoffersen C.
Sci Rep 7(1):14983. doi: 10.1038/s41598-017-15043-y. 2017
HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium.
Ruiz M, Okada H, Dahlbäck B.
Lipids Health Dis 16(1):36. doi: 10.1186/s12944-017-0429-2. 2017
Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism.
Ahmad A, Sundquist K, Zöller B, Dahlbäck B, Svensson PJ, Sundquist J, Memon AA.
Thromb Haemost 116(3):432-41. doi: 10.1160/TH16-03-0178. Epub 2016 Jun 9. 2016
ApoM Suppresses TNF-α-Induced Expression of ICAM-1 and VCAM-1 Through Inhibiting the Activity of NF-κB.
Gao JJ, Hu YW, Wang YC, Sha YH, Ma X, Li SF, Zhao JY, Lu JB, Huang C, Zhao JJ, Zheng L, Wang Q.
DNA Cell Biol 34(8):550-6. doi: 10.1089/dna.2015.2892. Epub 2015 Jun 9. 2015
Apolipoprotein M: Research progress, regulation and metabolic functions (Review).
Huang LZ, Gao JL, Pu C, Zhang PH, Wang LZ, Feng G, Zhang Y.
Mol Med Rep 12(2):1617-24. doi: 10.3892/mmr.2015.3658. Epub 2015 Apr 22. Review. 2015
Increased mRNA levels of apolipoprotein M and apolipoprotein AI in the placental tissues with fetal macrosomia.
Yu Y, Luo GH, Zhang J, Jiang H, Wei J, Shi YP, Zhang XY, Xu N.
Arch Gynecol Obstet 291(2):299-303. doi: 10.1007/s00404-014-3441-z. Epub 2014 Sep 7. 2015
Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate.
Sutter I, Park R, Othman A, Rohrer L, Hornemann T, Stoffel M, Devuyst O, von Eckardstein A.
J Lipid Res 55(8):1730-7. doi: 10.1194/jlr.M050021. Epub 2014 Jun 20. 2014
Apolipoprotein M promotes mobilization of cellular cholesterol in vivo.
Elsøe S, Christoffersen C, Luchoomun J, Turner S, Nielsen LB.
Biochim Biophys Acta 1831(7):1287-92. 2013
Association of the apolipoprotein M gene polymorphisms and serum lipid levels.
Aung LH, Yin RX, Wu DF, Yan TT, Li Q, Wu JZ, Lin WX, Liu CW, Pan SL.
Mol Biol Rep 40(2):1843-53. doi: 10.1007/s11033-012-2240-5. Epub 2012 Oct 21. 2013
Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL.
Elsøe S, Ahnström J, Christoffersen C, Hoofnagle AN, Plomgaard P, Heinecke JW, Binder CJ, Björkbacka H, Dahlbäck B, Nielsen LB.
Atherosclerosis 221(1):91-7. doi: 10.1016/j.atherosclerosis.2011.11.031. Epub 2011 Nov 27. 2012
Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M.
Christoffersen C, Obinata H, Kumaraswamy SB, Galvani S, Ahnström J, Sevvana M, Egerer-Sieber C, Muller YA, Hla T, Nielsen LB, Dahlbäck B.
Proc Natl Acad Sci U S A 108(23):9613-8. doi: 10.1073/pnas.1103187108. Epub 2011 May 23. 2011
Expression of apolipoprotein M in human hepatocellular carcinoma tissues.
Jiang J, Wu C, Luo G, Zheng L, Chen L, Zhang X, Xu N.
Acta Histochem 113(1):53-7. doi: 10.1016/j.acthis.2009.08.005. Epub 2009 Oct 1. 2011
Expression and localization of apolipoprotein M in human colorectal tissues.
Luo G, Zhang X, Mu Q, Chen L, Zheng L, Wei J, Berggren-Söderlund M, Nilsson-Ehle P, Xu N.
Lipids Health Dis 9:102. doi: 10.1186/1476-511X-9-102. 2010
Regulation of human apolipoprotein m gene expression by orphan and ligand-dependent nuclear receptors.
Mosialou I, Zannis VI, Kardassis D.
J Biol Chem 285(40):30719-30. doi: 10.1074/jbc.M110.131771. Epub 2010 Jul 26. 2010
ApoM: gene regulation and effects on HDL metabolism.
Nielsen LB, Christoffersen C, Ahnström J, Dahlbäck B.
Trends Endocrinol Metab 20(2):66-71. doi: 10.1016/j.tem.2008.11.003. Epub 2009 Feb 4. 2009
Apolipoprotein M associates to lipoproteins through its retained signal peptide.
Axler O, Ahnstršm J, DahlbŠck B.
FEBS Lett 582(5):826-8. Epub 2008 Feb 13. 2008
Characterization of apolipoprotein M isoforms in low-density lipoprotein.
Karlsson H, Lindqvist H, Tagesson C, Lindahl M.
J Proteome Res 5(10):2685-90. 2006
Isolation and characterization of human apolipoprotein M-containing lipoproteins.
Christoffersen C, Nielsen LB, Axler O, Andersson A, Johnsen AH, DahlbŠck B.
J Lipid Res 47(8):1833-43. Epub 2006 May 8. 2006
Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.
Xu N, Zhang XY, Dong X, Ekstrom U, Ye Q, Nilsson-Ehle P.
Biochem Biophys Res Commun 292(4):944-50. 2002
Proposed lipocalin fold for apolipoprotein M based on bioinformatics and site-directed mutagenesis.
Duan J, Dahlback B, Villoutreix BO.
FEBS Lett 499(1-2):127-32. 2001
A novel human apolipoprotein (apoM).
Xu N, Dahlback B.
J Biol Chem 274(44):31286-90. 1999
Localization of eight additional genes in the human major histocompatibility complex, including the gene encoding the casein kinase II beta subunit (CSNK2B).
Albertella MR, et al.
Genomics 36 : 240-251. 1996